GOLDENWELL BIOTECH, INC. (GWLL): auditor change — Goldenwell Biotech's auditor KCCW resigns; Michael Gillespie & Associates appointed

GOLDENWELL BIOTECH, INC.

KCCW resigned as independent registered public accounting firm on July 24, 2025, with no disagreements on accounting principles.
KCCW's reports for 2023 and 2024 included a going concern qualification about the company's ability to continue.
Board appointed Michael Gillespie & Associates as the new auditor on August 14, 2025; it previously served from Nov 2024 to Jan 2025.
No reportable events or disagreements occurred with either former or new auditor.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

GOLDENWELL BIOTECH, INC. engaged Michael Gillespie & Associates, PLLC as its auditor.

Action: engagement
Auditor: Michael Gillespie & Associates, PLLC

Exact text from the filing

On August 14, 2025, the board of directors of the Company resolved to engage the independent registered public accounting firm Michael Gillespie & Associates, PLLC (“Michael Gillespie & Associates”), as the Company’s new independent registered public accountants, which appointment Michael Gillespie & Associates has accepted.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

KCCW Accountancy Corp. resigned as auditor of GOLDENWELL BIOTECH, INC..

Action: resignation
Auditor: KCCW Accountancy Corp.

Exact text from the filing

On July 24, 2025, KCCW Accountancy Corp. (“KCCW”) notified Goldenwell Biotech, Inc. (the “Company”) it had resigned as the independent registered public accounting firm of the Company.

View on SEC.gov

8 auditor changes filed in the last 30 days. Browse all auditor changes →

GOLDENWELL BIOTECH, INC. filing history →

Source: SEC EDGAR

accession 0001477932-25-006051

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.